Camp4 Therapeutics Corp
CAMP · XNASCIK 1736730fmd_18AG7SXAST9TPPQ8C75TKYD953Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2023 to Sep 30, 2026, 15 periods
| Line item | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Total revenues | 0 | 1 | 3 |
| Research and development | 41 | 39 | 38 |
| Total operating expenses | 52 | 54 | 56 |
| Operating income | (52) | (53) | (53) |
| Interest and investment income | 3 | 1 | 2 |
| Other non-operating income (expense) | 3 | 1 | (28) |
| Income tax expense | 0 | 0 | 0 |
| Net income | (49) | (52) | (80) |
| Net income to common shareholders | – | (52) | (80) |